Monday, October 26, 2026 · Daily editionET --:--:--

Finished

SENTANTE: Fully Robotic Peripheral Endovascular Interventions

NCT06537947 · Inovatyvi Medicina UAB · Updated 16 May 2025

What is being tested
Endovascular intervention using the SENTANTE endovascular robotic system
For
Any Disease Which Requires Peripheral Endovascular Intervention
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 19 years to 90 years. About 10 people. The full rules are on the registry page.
Where
Latvia
When
Starts or started 19 July 2024, ends 30 Oct 2024. Registered 5 Aug 2024.
Results
None posted yet.

In the researchers' words

The objective of the study is to evaluate the feasibility, safety and initial efficacy of the clinical and technical performance of the SENTANTE robotic system in the remote delivery and manipulation of commonly used and compatible guidewires and catheter-based devices for use in peripheral endovascular procedures. The study will be a single-center, prospective investigation, designed to evaluate the safety, feasibility, and initial efficacy of robotic system for remote endovascular interventions in adults with disease which requires peripheral endovascular treatment with compatible devices. Participants meeting the inclusion criteria will undergo endovascular interventions using SENTANTE robotic system. Data will be collected through clinical assessments, imaging and other studies, laboratory tests, and feedback from medical personnel and patients. The study will adhere to ethical guidelines, obtain informed consent from all participants, and be conducted under the oversight of the Clinical Events Committee.
ClinicalTrials.gov, NCT06537947

Sites

  • Pauls Stradins Clinical university hospitalRiga, Latvia